E79.2 Myoadenylate deaminase deficiency

Name of the Condition

• Myoadenylate deaminase deficiency (ICD-10 Code: E79.2)

Summary

Myoadenylate deaminase deficiency is a genetic disorder affecting skeletal muscle metabolism, characterized by a deficiency of the enzyme adenylate deaminase (AMPD). This enzyme plays a key role in purine nucleotide metabolism during muscle activity. The condition may be asymptomatic or present with exercise intolerance, muscle pain, or cramping, though many individuals remain undiagnosed due to mild or absent symptoms. It is often identified incidentally during evaluation for other muscle-related concerns.

Causes

The disorder is caused by mutations in the AMPD1 gene, which encodes the muscle-specific isoform of adenylate deaminase. These mutations impair the enzyme's ability to function, disrupting the conversion of AMP to inosine monophosphate during muscle exertion. Inheritance is typically autosomal recessive, though some cases may occur sporadically.

Risk Factors

• Family history of myoadenylate deaminase deficiency or related metabolic muscle disorders.
• Consanguinity (increased likelihood of inheriting recessive genetic mutations).
• Participation in strenuous physical activities that may unmask subclinical symptoms.

Symptoms

• Exercise intolerance, particularly with prolonged or intense activity.
• Muscle pain, cramping, or fatigue during or after exercise.
• Asymptomatic presentation in many individuals, with diagnosis occurring incidentally.

Diagnosis

Diagnosis involves clinical evaluation of symptoms, followed by laboratory testing. Muscle biopsy may show reduced AMPD activity, and genetic testing can confirm mutations in the AMPD1 gene. Electromyography (EMG) or exercise testing may be used to assess muscle function, though results are often nonspecific. The condition is frequently identified when evaluating other muscle disorders.

Treatment Options

Treatment focuses on managing symptoms and may include:

• Adjusting exercise routines to avoid overexertion.
• Pain management for acute muscle discomfort.
• Physical therapy to improve muscle strength and endurance.
• No specific pharmacologic therapy exists for the underlying enzyme deficiency.

Prognosis and Follow-Up

Most individuals with myoadenylate deaminase deficiency have a favorable prognosis, especially if asymptomatic. For those with symptoms, lifestyle modifications and activity pacing can minimize discomfort. Regular follow-up is generally not required unless symptoms worsen or other muscle disorders are suspected.

Complications

• Exacerbation of exercise-related muscle pain or cramping.
• Misdiagnosis or unnecessary invasive testing if the condition is not recognized.
• Psychological impact from activity limitations in symptomatic cases.

Lifestyle & Prevention

• Gradual warm-up and cool-down during exercise to reduce muscle strain.
• Avoiding excessive or prolonged physical exertion.
• Maintaining overall muscle health through balanced activity and rest.

When to Seek Professional Help

Seek medical evaluation if you experience unexplained muscle pain, cramping, or fatigue during exercise, especially if symptoms interfere with daily activities or worsen over time.

Tips for Medical Coders

Document the clinical context, including symptoms (e.g., exercise intolerance, muscle pain) or diagnostic findings (e.g., reduced AMPD activity, genetic confirmation), to support code assignment. Ensure the code is used only when the condition is clinically documented and not as a standalone diagnosis without relevant clinical correlation.